Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male
population. The diagnosis, the identification of aggressive disease, and the post-treatment …

In prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of
diagnosis and staging, refined surveillance strategies, and introduced specific and …

Background Early diagnosis of tumor metastasis is crucial for clinical treatment. Artificial
intelligence (AI) has shown great promise in the field of medicine. We therefore aimed to …

Prostate cancer (PCa) is one of the most frequently diagnosed malignancies of men in the
world. Due to a variety of treatment options in different risk groups, proper diagnostic and …

Objective The aim of this study was (1) to investigate the application of texture analysis of
choline PET/CT images in prostate cancer (PCa) patients and (2) to propose a machine …

Background It is important to diagnose sclerotic bone lesions in order to determine treatment
strategy. Purpose To evaluate the diagnostic performance of a CT radiomics–based …

Prostate cancer is the second most common cause of malignancy among men, with bone
metastasis being a significant source of morbidity and mortality in advanced cases …

Purpose. Artificial intelligence (AI) techniques are used in precision medicine to explore
novel genotypes and phenotypes data. The main aims of precision medicine include early …

Metastatic Prostate Cancer (mPCa) is associated with a poor patient prognosis. mPCa
spreads throughout the body, often to bones, with spatial and temporal variations that make …

Radiotheranostics refers to the pairing of radioactive imaging biomarkers with radioactive
therapeutic compounds that deliver ionizing radiation. Given the introduction of very …